Edition:
United Kingdom

People: BioTelemetry Inc (BEAT.OQ)

BEAT.OQ on NASDAQ Stock Exchange Global Select Market

46.56USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$46.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
170,860
52-wk High
$80.80
52-wk Low
$46.19

Conti, Anthony 

Mr. Anthony J. Conti serves as Independent Director of BioTelemetry, Inc. (formely CardioNet, Inc.). Mr. Conti is retired from his position as a Partner at PricewaterhouseCoopers LLP. He joined Coopers and Lybrand in 1973 and served a wide range of technology, utility and health services clients. He held a number of leadership roles with Coopers and Lybrand, and later with PricewaterhouseCoopers LLP, after its merger with Price Waterhouse in 1998. Mr. Conti serves as the lead independent director and chairman of the audit committee for Ametek Inc., an electronic instrument and electromechanical device company. He also serves on the advisory boards of two privately held companies: Progressive Business Publications and PEI Genesis Company. Mr. Conti is also chairman of the board of the Philadelphia Foundation and vice chairman of the board of the Satell Institute.

Basic Compensation

Total Annual Compensation, USD 73,125
Restricted Stock Award, USD 130,033
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 203,158

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kirk Gorman

230,658

Joseph Capper

3,875,560

Heather Getz

1,632,580

Fred Broadway

1,007,410

Peter Ferola

917,995

Daniel Wisniewski

935,098
As Of  31 Dec 2018